The Government Affairs Committee is comprised of BioCT board members, industry executives and business advisors including the government relations firm of Rome, Smith, Lutz & Kowalski, which has deep expertise in matters impacting our industry.
Jodie Gillon
President & CEO,
BioCT
Christopher Smith
Partner,
Rome, Smith, Lutz & Kowalski
John Harkins
Vice President,
Rome, Smith, Lutz & Kowalski
Joseph Oros
Director, State Government Affairs
AbbVie
Matthew O’Donnell
Senior Director, State Government Affairs,
Alexion, AstraZeneca Rare Disease
Brian Rosen
Director, State Government Affairs, East
Alexion, AstraZeneca Rare Disease
Stephen Burm
Director, State Government Affairs,
Northeast Region
BIO
Jennifer Herz
State Government Affairs, Regional Director,
Boehringer Ingelheim
Dmitri Siegel
Director, Alliance Development,
Bristol Myers Squibb
Joni Arvai
Senior Manager, State Government Affairs,
Bristol Myers Squibb
Karla White
State Government Affairs Manager, East Coast,
CSL Behring
Rich Horgan
Founder and CEO,
CURE Rare Disease
Kathy Andrews Bilotas
Director of State Government Affairs,
Eli Lilly
Bill Claffey
Partner, Tax Services,
Fiondella, Milone & LaSaracina
Sandra Ribeiro
Director, State Government Affairs,
GSK
Lisa Roy
Director of Government & Community Relations,
The Jackson Laboratory for Genomic Medicine
John Kocinsky
Executive VP, Technical Opperations,
Mannkind
Kenneth Hiscoe
Government Relations Director,
Pfizer
Laura Ekas
SVP, Head of Corporate & Commercial Strategy,
Rallybio
Valerie Volpe
Federal Liason
Regeneron
Kathryn Lavriha
Director, State Government Relations,
Sanofi
Marie DeSanto Schweitzer
Director, Government Relations for Health Affairs,
University of Connecticut
Joann Lombardo
Senior Director, Governmental Relations,
University of Connecticut
Jillian Jackson
Associate Director of State Relations,
Yale University